AVEO Oncology is the latest life science company to partner with Annexus Health. Oncology providers can now enroll eligible patients in the AVEO ACE Program directly within our AssistPoint platform, which also enables them to track the status and spend down of the co-pay award.
Through partnerships like this one, Annexus Health continues to make strides toward reducing the financial and administrative burdens across the patient access journey.
AVEO is an oncology-focused biopharmaceutical company committed to delivering medicines that provide a better life for cancer patients. For more information on AVEO ACE, visit aveooncology.com.
AssistPoint is a single enterprise workflow platform that helps provider organizations navigate and manage the patient access journey.
Life science organizations and charitable foundations can integrate their patient support programs with AssistPoint through AP Connect®, creating a two-way, secure information exchange to:
- Improve overall program user experience
- Reduce program communication delays
- Streamline the application, enrollment, and fulfillment process
- Speed up award approval notification for appropriate patients based on eligibility
- Enable immediate access to award balance
About Annexus Health
Annexus Health is the leading healthcare technology company that is revolutionizing the patient access journey by delivering innovative solutions, including tech-enabled services, that reduce financial and administrative burdens to improve access, speed, and adherence to critical care.
